论文部分内容阅读
目的探讨磷酸阿糖腺苷治疗小儿疱疹性口腔炎的临床疗效。方法选取烟台市妇幼保健院2012年1月—2013年10月收治的疱疹性口腔炎的患儿164例,随机分为观察组75例和对照组89例。观察组给予单磷酸阿糖腺苷治疗,对照组给予利巴韦林治疗,比较两组患儿的退热时间、疱疹消失时间及临床疗效。结果观察组总有效率(94.6%)高于对照组(77.5%),疱疹消退时间及退热时间短于对照组,差异有统计学意义(P<0.05)。结论单磷酸阿糖腺苷治疗小儿疱疹性口腔炎的疗效确切。
Objective To investigate the clinical efficacy of vidarabine in the treatment of pediatric herpetic stomatitis. Methods 164 cases of herpes stomatitis admitted to Yantai MCH from January 2012 to October 2013 were randomly divided into observation group (n = 75) and control group (n = 89). The observation group was treated with vidarabine monophosphate. The control group was treated with ribavirin. The antipyretic time, the disappearance of herpes and the clinical effect were compared between the two groups. Results The total effective rate (94.6%) in the observation group was significantly higher than that in the control group (77.5%). Herpes remission and antipyretic time were shorter than those in the control group (P <0.05). Conclusion The efficacy of monophosphate adenosine monophosphate in the treatment of pediatric herpetic stomatitis is accurate.